NervGen Pharma Corp. Common stock (NGEN) is a publicly traded the market company. As of November 12, 2026, NGEN trades at $1.43 with a market cap of $143.01M and a P/E ratio of 0.00. NGEN moved +5.85% today. Year to date, NGEN is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $1.28 to $6.30. Analyst consensus is buy with an average price target of $10.00. Rallies surfaces NGEN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
NervGen Pharma Corp. Common stock (NGEN) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. NGEN moved +5.85% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $1.43 |
| Market Cap | $143.01M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.30 |
| 52-Week Low | $1.28 |
| Volume | 142.01K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
2 analysts cover NGEN: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $10.00.